ESC/EAS Guidelines for the management of dyslipidaemias

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works

General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study

D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491 · see citing works

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449 · see citing works

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439 · see citing works

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992 · see citing works

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807646 · Cited by 6,674 · see citing works

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

Cholesterol Treatment Trialists' (CTT) Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)61350-5 · Cited by 6,550 · see citing works

Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project

Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290 · see citing works

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261 · see citing works

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS

Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236 · see citing works

Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881 · see citing works

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial

(1999) · The Lancet · doi:10.1016/s0140-6736(99)07072-5 · Cited by 3,812 · see citing works

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Sever, P., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M. J., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12948-0 · Cited by 3,757 · see citing works

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Colhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755 · see citing works

Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease

LaRosa, J. C., Grundy, S. M., Waters, D. D., Shear, C., Barter, P., Fruchart, J.-C., Gotto, A. M., Greten, H., Kastelein, J. J. P., Shepherd, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050461 · Cited by 3,489 · see citing works

Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · see citing works

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378 · see citing works

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

(2005) · The Lancet · doi:10.1016/s0140-6736(05)67667-2 · Cited by 3,284 · see citing works

Effects of torcetrapib in patients at high risk for coronary events

Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139 · see citing works

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Pedersen, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,098 · see citing works

The Metabolic Syndrome and Cardiovascular Risk

Mottillo, S., Filion, K. B., Genest, J., Joseph, L., Pilote, L., Poirier, P., Rinfret, S., Schiffrin, E. L., & Eisenberg, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.034 · Cited by 3,009 · see citing works

High-Dose Atorvastatin after Stroke or Transient Ischemic Attack

The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061894 · Cited by 2,887 · see citing works

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

(2003) · The Lancet · doi:10.1016/s0140-6736(03)13636-7 · Cited by 2,876 · see citing works

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · see citing works

Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials

Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · see citing works

Major lipids, apolipoproteins, and risk of vascular disease

The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731 · see citing works

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614 · see citing works

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516 · see citing works

Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>

Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499 · see citing works

Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials

Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436 · see citing works

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation

Authors Task Force Members, de Werf, F. V., Bax, J. J., Betriu, A., Blomström‐Lundqvist, C., Crea, F., Falk, V., Filippatos, G. S., Fox, K. A. A., Huber, K., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn416 · Cited by 2,294 · see citing works

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

Brown, G., Albers, J. J., Fisher, L. D., Schaefer, S. M., Lin, J.-T., Kaplan, C., Zhao, X.-Q., Bisson, B. D., Fitzpatrick, V. F., & Dodge, H. T. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231901 · Cited by 2,159 · see citing works

Estrogen plus Progestin and the Risk of Coronary Heart Disease

Manson, J. E., Hsia, J., Johnson, K. C., Rossouw, J. E., Assaf, A. R., Lasser, N. L., Trevisan, M., Black, H. R., Heckbert, S. R., Detrano, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030808 · Cited by 2,065 · see citing works

Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women

Nordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058 · see citing works

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

Fellström, B. C., Jardine, A. G., Schmieder, R. E., Holdaas, H., Bannister, K., Beutler, J., Chae, D.-W., Chevaile, A., Cobbe, S. M., Grönhagen-Riska, C., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810177 · Cited by 2,036 · see citing works

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

Brown, B. G., Zhao, X.-Q., Chait, A., Fisher, L. D., Cheung, M. C., Morse, J. S., Dowdy, A. A., Marino, E. K., Bolson, E. L., Alaupovic, P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011090 · Cited by 1,979 · see citing works

Statins for the primary prevention of cardiovascular disease

Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934 · see citing works

Cholesterol-lowering effects of dietary fiber: a meta-analysis

Brown, L., Rosner, B., Willett, W. W., & Sacks, F. M. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.1.30 · Cited by 1,857 · see citing works

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

Bassand, J., Hamm, C. W., Ardissino, D., Boersma, E. H., Budaj, A., Fernández‐Avilés, F., Fox, K. A. A., Hasdai, D., Ohman, E. M., Wallentin, L. C., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm161 · Cited by 1,850 · see citing works

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

Canner, P. L., Berge, K. G., Wenger, N. K., Stamler, J., Friedman, L., Prineas, R. J., & Friedewald, W. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80293-5 · Cited by 1,824 · see citing works

Lipoprotein(a) as a cardiovascular risk factor: current status

Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807 · see citing works

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765 · see citing works

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality

(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753 · see citing works

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: systematic review and meta-analysis

Law, M. R., Wald, N. J., & Rudnicka, A. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1423 · Cited by 1,720 · see citing works

Untitled work

Graham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647 · see citing works

Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis

Rossebø, A. B., Pedersen, T. R., Boman, K., Brudi, P., Chambers, J. B., Egstrup, K., Gerdts, E., Gohlke-Bärwolf, C., Holme, I., Kesäniemi, Y. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804602 · Cited by 1,644 · see citing works

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women

Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619 · see citing works

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events

Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610 · see citing works

Effects of the amount and intensity of exercise on plasma lipoproteins

Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020194 · Cited by 1,554 · see citing works

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction<SUBTITLE>The IDEAL Study: A Randomized Controlled Trial</SUBTITLE>

Pedersen, T. R. (2005) · JAMA · doi:10.1001/jama.294.19.2437 · Cited by 1,548 · see citing works

Optimal Diets for Prevention of Coronary Heart Disease

Hu, F. B. (2002) · JAMA · doi:10.1001/jama.288.20.2569 · Cited by 1,503 · see citing works

Rosuvastatin in older patients with systolic heart failure

Kjekshus, J., Apetrei, E., Barrios, V., Böhm, M., Cleland, J. G. F., Cornel, J. H., Dunselman, P., Fonseca, C., Goudev, A., Grande, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706201 · Cited by 1,487 · see citing works

Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors

Rimm, E. B., Williams, P., Fosher, K., Criqui, M., & Stampfer, M. J. (1999) · BMJ · doi:10.1136/bmj.319.7224.1523 · Cited by 1,360 · see citing works

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350 · see citing works

Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes: Phase Z of the A to Z Trial

de Lemos, J. A., Blazing, M. A., Wiviott, S. D., Lewis, E. F., Fox, K. A. A., White, H. D., Rouleau, J.-L., Pedersen, T. R., Gardner, L. H., Mukherjee, R., et al. (2004) · JAMA · doi:10.1001/jama.292.11.1307 · Cited by 1,333 · see citing works

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

Peters, M. J. L., Symmons, D. P. M., McCarey, D., Dijkmans, B. A. C., Nicola, P., Kvien, T. K., McInnes, I. B., Haentzschel, H., Gonzalez-Gay, M. A., Provan, S., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.113696 · Cited by 1,325 · see citing works

Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione

Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M. G., Geraci, E., Levantesi, G., Maggioni, A. P., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014682.14181.f2 · Cited by 1,311 · see citing works

Effect of pravastatin on outcomes after cardiac transplantation

Kobashigawa, J. A., Katznelson, S., Laks, H., Johnson, J. A., Yeatman, L., Wang, X. M., Chia, D., Terasaki, P. I., Sabad, A., Cogert, G. A., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331003 · Cited by 1,301 · see citing works

Secondary Prevention by Raising HDL Cholesterol and Reducing Triglycerides in Patients With Coronary Artery Disease: The Bezafibrate Infarction Prevention (BIP) Study

(2000) · Circulation · doi:10.1161/01.cir.102.1.21 · Cited by 1,273 · see citing works

A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease

Mente, A., de Koning, L., Shannon, H. S., & Anand, S. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.38 · Cited by 1,267 · see citing works

n-3 fatty acids and serum lipoproteins: human studies

Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243 · see citing works

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227 · see citing works

Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

Second Joint Task Force of European (1998) · European Heart Journal · doi:10.1053/euhj.1998.1243 · Cited by 1,131 · see citing works

Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61240-4 · Cited by 1,106 · see citing works

Low-Fat Dietary Pattern and Risk of Cardiovascular Disease: The Women's Health Initiative Randomized Controlled Dietary Modification Trial

Howard, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091 · see citing works

Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis

Dattilo, A., & Kris-Etherton, P. (1992) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.2.320 · Cited by 1,055 · see citing works

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Ridker, P. M., Danielson, E., Fonseca, F. A., Genest, J., Gotto, A. M., Kastelein, J. J., Koenig, W., Libby, P., Lorenzatti, A. J., MacFadyen, J. G., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60447-5 · Cited by 1,010 · see citing works

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

Rasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975 · see citing works

Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors: A Meta-analysis of Randomized Controlled Trials

Nordmann, A. J., Nordmann, A., Briel, M., Keller, U., Yancy, W. S., Brehm, B. J., & Bucher, H. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.3.285 · Cited by 973 · see citing works

Exercise for overweight or obesity

Shaw, K. A., Gennat, H. C., O'Rourke, P., & Del Mar, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003817.pub3 · Cited by 950 · see citing works

n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction

Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936 · see citing works

Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis

Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A., Chalmers, J., & Perkovic, V. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60656-3 · Cited by 933 · see citing works

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M., Cromwell, W. C., Lachmann, R., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 921 · see citing works

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

Holdaas, H., Fellström, B., Jardine, A. G., Holme, I., Nyberg, G., Fauchald, P., Grönhagen-Riska, C., Madsen, S., Neumayer, H.-H., Cole, E., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13638-0 · Cited by 919 · see citing works

Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome

Adiels, M., Olofsson, S.-O., Taskinen, M.-R., & Borén, J. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.160192 · Cited by 820 · see citing works

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

Kotseva, K., Wood, D., Backer, G. D., Bacquer, D. D., Pyörälä, K., Keil, U., & EUROASPIRE Study Group (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283294b1d · Cited by 812 · see citing works

Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention

Harris, W. S., Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, L. L., Appel, L. J., Engler, M. M., Engler, M. B., & Sacks, F. (2009) · Circulation · doi:10.1161/circulationaha.108.191627 · Cited by 794 · see citing works

The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials

Brugts, J. J., Yetgin, T., Hoeks, S. E., Gotto, A. M., Shepherd, J., Westendorp, R. G. J., de Craen, A. J. M., Knopp, R. H., Nakamura, H., Ridker, P., et al. (2009) · BMJ · doi:10.1136/bmj.b2376 · Cited by 792 · see citing works

Cardiovascular and noncardiovascular mortality among patients starting dialysis

de Jager, D. J. (2009) · JAMA · doi:10.1001/jama.2009.1488 · Cited by 755 · see citing works

Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis

Amarenco, P., Labreuche, J., Lavallée, P., & Touboul, P.-J. (2004) · Stroke · doi:10.1161/01.str.0000147965.52712.fa · Cited by 746 · see citing works

Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review

Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.012 · Cited by 732 · see citing works

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

Laing, S. P., Swerdlow, A. J., Slater, S. D., Burden, A. C., Morris, A., Waugh, N. R., Gatling, W., Bingley, P. J., & Patterson, C. C. (2003) · Diabetologia · doi:10.1007/s00125-003-1116-6 · Cited by 724 · see citing works

Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis

Nicholls, S. J., Tuzcu, E. M., Sipahi, I., Grasso, A. W., Schoenhagen, P., Hu, T., Wolski, K., Crowe, T., Desai, M. Y., Hazen, S. L., et al. (2007) · JAMA · doi:10.1001/jama.297.5.499 · Cited by 724 · see citing works

Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention A Randomized Controlled Trial

Serruys, P. W. J. C. (2002) · JAMA · doi:10.1001/jama.287.24.3215 · Cited by 716 · see citing works

Diabetes and mortality following acute coronary syndromes

Donahoe, S. M., Stewart, G. C., McCabe, C. H., Mohanavelu, S., Murphy, S. A., Cannon, C. P., & Antman, E. M. (2007) · JAMA · doi:10.1001/jama.298.7.765 · Cited by 716 · see citing works

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716 · see citing works

Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review

Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C. D., Ness, A. R., Moore, H. J., Worthington, H. V., Durrington, P. N., Higgins, J. P. T., Capps, N. E., et al. (2006) · BMJ · doi:10.1136/bmj.38755.366331.2f · Cited by 676 · see citing works

Health effects of trans-fatty acids: experimental and observational evidence

Mozaffarian, D., Aro, A., & Willett, W. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602973 · Cited by 662 · see citing works

Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention

Amarenco, P., & Labreuche, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70058-4 · Cited by 660 · see citing works

A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk

Sniderman, A. D., Williams, K., Contois, J. H., Monroe, H. M., McQueen, M. J., de Graaf, J., & Furberg, C. D. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.959247 · Cited by 659 · see citing works

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

Wood, D., Kotseva, K., Connolly, S., Jennings, C., Mead, A., Jones, J., Holden, A., De Bacquer, D., Collier, T., De Backer, G., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60868-5 · Cited by 601 · see citing works

Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial

Durazzo, A. E. S., Machado, F. S., Ikeoka, D. T., De Bernoche, C., Monachini, M. C., Puech-Leão, P., & Caramelli, B. (2004) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.01.004 · Cited by 595 · see citing works

Fasting and Nonfasting Lipid Levels: Influence of Normal Food Intake on Lipids, Lipoproteins, Apolipoproteins, and Cardiovascular Risk Prediction

Langsted, A., Freiberg, J. J., & Nordestgaard, B. G. (2008) · Circulation · doi:10.1161/circulationaha.108.804146 · Cited by 588 · see citing works

Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia

Cuchel, M., Bloedon, L. T., Szapary, P. O., Kolansky, D. M., Wolfe, M. L., Sarkis, A., Millar, J. S., Ikewaki, K., Siegelman, E. S., Gregg, R. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061189 · Cited by 580 · see citing works

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome

Scott, R., O'Brien, R., Fulcher, G., Pardy, C., d'Emden, M., Tse, D., Taskinen, M.-R., Ehnholm, C., Keech, A., & on behalf of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study Investigators (2009) · Diabetes Care · doi:10.2337/dc08-1543 · Cited by 551 · see citing works

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

Hippisley‐Cox, J., & Coupland, C. A. C. (2010) · BMJ · doi:10.1136/bmj.c2197 · Cited by 511 · see citing works

Statins for Improving Renal Outcomes

Sandhu, S., Wiebe, N., Fried, L. F., & Tonelli, M. A. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010012 · Cited by 473 · see citing works

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia

Fruchart, J.-C., Sacks, F., Hermans, M. P., Assmann, G., Brown, W. V., Ceska, R., Chapman, M. J., Dodson, P. M., Fioretto, P., Ginsberg, H. N., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.10.002 · Cited by 463 · see citing works

Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women

Liu, S., Manson, J. E., Stampfer, M. J., Holmes, M. D., Hu, F. B., Hankinson, S. E., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.3.560 · Cited by 454 · see citing works

Mechanism of action of niacin

Kamanna, V. S., & Kashyap, M. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.029 · Cited by 453 · see citing works

Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation: A Four-Year Randomized Trial

Wenke, K., Meiser, B., Thiery, J., Nagel, D., von Scheidt, W., Steinbeck, G., Seidel, D., & Reichart, B. (1997) · Circulation · doi:10.1161/01.cir.96.5.1398 · Cited by 444 · see citing works

Atherosclerosis and Coronary Artery Disease

(1996) · Nature Medicine · doi:10.1038/nm0796-822 · Cited by 441 · see citing works

European guidelines on cardiovascular disease prevention in clinical practice Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)

Backer, G. D., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. M., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/00149831-200308000-00004 · Cited by 440 · see citing works

Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk

Cooney, M. T., Dudina, A. L., & Graham, I. M. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.020 · Cited by 436 · see citing works

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force

McKenney, J. M., Davidson, M. H., Jacobson, T. A., & Guyton, J. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.030 · Cited by 431 · see citing works

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial

Lewis, S. J., Moye, L. A., Sacks, F. M., Johnstone, D. E., Timmis, G., Mitchell, J., Limacher, M., Kell, S., Glasser, S. P., Grant, J., et al. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00002 · Cited by 427 · see citing works

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

Neil, A., Cooper, J., Betteridge, J., Capps, N., McDowell, I., Durrington, P., Seed, M., Humphries, S. E., & on behalf of the Simon Broome Familial Hyperlipidaemia Register Group (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn422 · Cited by 425 · cited 2× · see citing works

Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments

Mills, E. J., Rachlis, B., Wu, P., Devereaux, P. J., Arora, P., & Perri, D. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.039 · Cited by 423 · see citing works

Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S

Ballantyne, C. M., Olsson, A. G., Cook, T. J., Mercuri, M. F., Pedersen, T. R., & Kjekshus, J. (2001) · Circulation · doi:10.1161/hc5001.100624 · Cited by 416 · see citing works

Safety considerations with fibrate therapy

Davidson, M. H., Armani, A., McKenney, J. M., & Jacobson, T. A. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.016 · Cited by 408 · see citing works

Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin

Jones, P. H., & Davidson, M. H. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.076 · Cited by 387 · see citing works

The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease

Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386 · see citing works

Efficacy and tolerability of adding prescription Omega-3 fatty acids 4 g/d to Simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study

Davidson, M. H., Stein, E. A., Bays, H. E., Maki, K. C., Doyle, R. T., Shalwitz, R. A., Ballantyne, C. M., & Ginsberg, H. N. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.07.018 · Cited by 385 · see citing works

LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA)

Mora, S., Szklo, M., Otvos, J. D., Greenland, P., Psaty, B. M., Goff, D. C., O’Leary, D. H., Saad, M. F., Tsai, M. Y., & Sharrett, A. R. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.007 · Cited by 380 · see citing works

Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery

Schouten, O., Boersma, E., Hoeks, S. E., Benner, R., van Urk, H., van Sambeek, M. R. H. M., Verhagen, H. J. M., Khan, N. A., Dunkelgrun, M., Bax, J. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808207 · Cited by 374 · see citing works

Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk

Robinson, J. G., Wang, S., Smith, B. J., & Jacobson, T. A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.024 · Cited by 368 · see citing works

Early and Late Benefits of High-Dose Atorvastatin in Patients With Acute Coronary Syndromes

Ray, K. K., Cannon, C. P., McCabe, C. H., Cairns, R., Tonkin, A. M., Sacks, F. M., Jackson, G., & Braunwald, E. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.03.077 · Cited by 356 · see citing works

Use of the Thyroid Hormone Analogue Eprotirome in Statin-Treated Dyslipidemia

Ladenson, P. W., Kristensen, J. D., Ridgway, E. C., OLSSON, A. G., Carlsson, B., Klein, I. L., Baxter, J. D., & Angelin, B. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905633 · Cited by 337 · see citing works

Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension

Pyörälä, K., DeBacker, G., Graham, I. D., Poole-Wilson, P. A., & Wood, D. A. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90200-3 · Cited by 327 · see citing works

Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

SHARP Collaborative Group (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.08.012 · Cited by 319 · see citing works

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.003 · Cited by 316 · see citing works

Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention

Di Sciascio, G., Patti, G., Pasceri, V., Gaspardone, A., Colonna, G., & Montinaro, A. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.028 · Cited by 315 · see citing works

Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction

Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., & Capuzzi, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.056 · Cited by 315 · see citing works

Effects of dietary fructose on plasma lipids in healthy subjects

Bantle, J. P., Raatz, S. K., Thomas, W. T. B., & Georgopoulos, A. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1128 · Cited by 312 · see citing works

Effectiveness and tolerability of simvastatin plus fenofibrate for combined hyperlipidemia (the SAFARI trial)

Grundy, S. M., Vega, G. L., Yuan, Z., Battisti, W. P., Brady, W. E., & Palmisano, J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.10.012 · Cited by 309 · see citing works

Statins for the primary prevention of cardiovascular disease

Taylor, F. C., Ward, K. J., Moore, T. H., Burke, M., Smith, G. D., Casas, J. P., & Ebrahim, S. B. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub4 · Cited by 305 · see citing works

Cardiovascular morbidity in psoriatic arthritis

Gladman, D. D., Ang, M., Su, L., Tom, B. D. M., Schentag, C. T., & Farewell, V. T. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094839 · Cited by 304 · see citing works

Report of the national heart, lung, and blood institute workshop on lipoprotein(a) and cardiovascular disease: recent advances and future directions

Marcovina, S. M., Koschinsky, M. L., Albers, J. J., & Skarlatos, S. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023689 · Cited by 288 · see citing works

Contraceptive hormone use and cardiovascular disease

Shufelt, C. L., & Bairey Merz, C. N. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.042 · Cited by 287 · see citing works

Reduction of Stroke Events With Pravastatin

Byington, R. P., Davis, B. R., Plehn, J. F., White, H. D., Baker, J., Cobbe, S. M., & Shepherd, J. (2001) · Circulation · doi:10.1161/01.cir.103.3.387 · Cited by 276 · see citing works

Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients: A Randomized Trial

Becker, D. J., Gordon, R. Y., Halbert, S. C., French, B., Morris, P. B., & Rader, D. J. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00006 · Cited by 275 · see citing works

Severe hypertriglyceridemia and pancreatitis: presentation and management

Ewald, N., Hardt, P. D., & Kloer, H.-U. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283319a1d · Cited by 273 · see citing works

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis

Bruckert, E., Labreuche, J., & Amarenco, P. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.12.023 · Cited by 273 · see citing works

Drug Treatment of Hyperlipidemia in Women

Walsh, J. M. E. (2004) · JAMA · doi:10.1001/jama.291.18.2243 · Cited by 270 · see citing works

Safety considerations with niacin therapy

Guyton, J. R., & Bays, H. E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.11.018 · Cited by 269 · see citing works

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk

Humphries, S. E., Whittall, R. A., Hubbart, C. S., Maplebeck, S., Cooper, J. A., Soutar, A. K., Naoumova, R., Thompson, G. R., Seed, M., Durrington, P. N., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.038356 · Cited by 267 · see citing works

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk

Cooney, M. T., Dudina, A., De Bacquer, D., Wilhelmsen, L., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., Thomsen, T., et al. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.041 · Cited by 250 · cited 20× · see citing works

Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function

Lee, J. M. S., Robson, M. D., Yu, L.-M., Shirodaria, C. C., Cunnington, C., Kylintireas, I., Digby, J. E., Bannister, T., Handa, A., Wiesmann, F., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.06.036 · Cited by 246 · cited 2× · see citing works

Meta-Analysis: The Effect of Statins on Albuminuria

Douglas, K., O’Malley, P. G., & Jackson, J. L. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-2-200607180-00009 · Cited by 246 · see citing works

Familial hypercholesterolaemia: summary of NICE guidance

Wierzbicki, A. S., Humphries, S. E., Minhas, R., & on behalf of the Guideline Development Group (2008) · BMJ · doi:10.1136/bmj.a1095 · Cited by 237 · see citing works

Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk

Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227 · cited 2× · see citing works

Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project)

Canner, P. L., Furberg, C. D., Terrin, M. L., & McGovern, M. E. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.09.013 · Cited by 226 · see citing works

The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)

Villines, T. C., Stanek, E. J., Devine, P. J., Turco, M., Miller, M., Weissman, N. J., Griffen, L., & Taylor, A. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.017 · Cited by 223 · see citing works

Cardiovascular Risk-Estimation Systems in Primary Prevention: Do They Differ? Do They Make a Difference? Can We See the Future?

Cooney, M. T., Dudina, A., D'Agostino, R., & Graham, I. M. (2010) · Circulation · doi:10.1161/circulationaha.109.852756 · Cited by 222 · see citing works

Effect of lifestyle intervention on the occurrence of metabolic syndrome and its components in the Finnish Diabetes Prevention Study

Ilanne-Parikka, P., Eriksson, J. G., Lindström, J., Peltonen, M., Aunola, S., Hämäläinen, H., Keinänen-Kiukaanniemi, S., Laakso, M., Valle, T. T., Lahtela, J., et al. (2008) · Diabetes Care · doi:10.2337/dc07-1117 · Cited by 218 · see citing works

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV^*

Lundgren, J., Battegay, M., Behrens, G., De Wit, S., Guaraldi, G., Katlama, C., Martinez, E., Nair, D., Powderly, W., Reiss, P., et al. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00534.x · Cited by 210 · see citing works

Lipid-lowering for peripheral arterial disease of the lower limb

Aung, P. P., Maxwell, H., Jepson, R. G., Price, J. F., & Leng, G. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000123.pub2 · Cited by 206 · see citing works

Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study)

Ballantyne, C. M., Weiss, R., Moccetti, T., Vogt, A., Eber, B., Sosef, F., & Duffield, E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.10.022 · Cited by 196 · see citing works

Serum cholesterol response to dietary cholesterol

Keys, A. B. (1984) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/40.2.351 · Cited by 188 · see citing works

Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 Study

Scirica, B. M., Morrow, D. A., Cannon, C. P., Ray, K. K., Sabatine, M. S., Jarolim, P., Shui, A., McCabe, C. H., & Braunwald, E. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.03.034 · Cited by 181 · see citing works

Relation of atherosclerotic changes in retinal arteries to the extent of coronary artery disease

Tedeschi-Reiner, E., Strozzi, M., Skoric, B., & Reiner, Z. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.05.070 · Cited by 178 · see citing works

Ten-year risk of cardiovascular incidence related to diabetes, prediabetes, and the metabolic syndrome

Liu, J., Grundy, S. M., Wang, W., Smith, S. C., Lena Vega, G., Wu, Z., Zeng, Z., Wang, W., & Zhao, D. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.003 · Cited by 177 · cited 6× · see citing works

Effect of High-Dose Atorvastatin on Hospitalizations for Heart Failure: Subgroup Analysis of the Treating to New Targets (TNT) Study

Khush, K. K., Waters, D. D., Bittner, V., Deedwania, P. C., Kastelein, J. J. P., Lewis, S. J., & Wenger, N. K. (2007) · Circulation · doi:10.1161/circulationaha.106.625574 · Cited by 172 · see citing works

Effect of Policosanol on Lipid Levels Among Patients With Hypercholesterolemia or Combined Hyperlipidemia

Berthold, H. K., Unverdorben, S., Degenhardt, R., Bulitta, M., & Gouni‐Berthold, I. (2006) · JAMA · doi:10.1001/jama.295.19.2262 · Cited by 167 · see citing works

Basic data concerning associated coronary disease in peripheral vascular patients

Hertzer, N. R. (1987) · Annals of Vascular Surgery · doi:10.1016/s0890-5096(06)61452-0 · Cited by 161 · see citing works

Effect of pravastatin in people with diabetes and chronic kidney disease

Tonelli, M., Keech, A., Shepherd, J., Sacks, F., Tonkin, A., Packard, C., Pfeffer, M., Simes, J., Isles, C., Furberg, C., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070779 · Cited by 159 · see citing works

Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study

Glass, T., Ungsedhapand, C., Wolbers, M., Weber, R., Vernazza, P., Rickenbach, M., Furrer, H., Bernasconi, E., Cavassini, M., Hirschel, B., et al. (2006) · HIV Medicine · doi:10.1111/j.1468-1293.2006.00400.x · Cited by 156 · see citing works

Untitled work

Veenkamp (2002) · doi:10.1161/hq0202.104059 · Cited by 152 · see citing works

Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study)

McKenney, J. M., Jones, P. H., Bays, H. E., Knopp, R. H., Kashyap, M. L., Ruoff, G. E., & McGovern, M. E. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.11.037 · Cited by 150 · see citing works

Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey

Reiner, Ž., Sonicki, Z., & Tedeschi-Reiner, E. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.09.014 · Cited by 148 · see citing works

Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis

Petretta, M., Costanzo, P., Perrone-Filardi, P., & Chiariello, M. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.08.001 · Cited by 141 · see citing works

Guar gum and similar soluble fibers in the regulation of cholesterol metabolism: Current understandings and future research priorities

Rideout, T. C. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3512 · Cited by 137 · see citing works

Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease

McDermott, M. M., Mandapat, A. L., Moates, A., Albay, M., Chiou, E., Celic, L., & Greenland, P. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.18.2157 · Cited by 135 · see citing works

Alcohol Consumption and Risk for Coronary Heart Disease among Men with Hypertension

Beulens, J. W. J., Rimm, E. B., Ascherio, A., Spiegelman, D. L., Hendriks, H., & Mukamal, K. J. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-1-200701020-00004 · Cited by 133 · see citing works

Selecting target conditions for quality of care improvement in vulnerable older adults

Sloss, E. M., Solomon, D. H., Shekelle, P. G., Young, R. T., Saliba, D., MacLean, C. H., Rubenstein, L. Z., Schnelle, J. F., Kamberg, C. J., & Wenger, N. S. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb04691.x · Cited by 132 · see citing works

Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence

Fonseca, V. A., Handelsman, Y., & Staels, B. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01181.x · Cited by 130 · see citing works

Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors

MAS, R., CASTANO, G., ILLNAIT, J., FERNANDEZ, L., FERNANDEZ, J., ALEMAN, C., PONTIGAS, V, & LESCAY, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70139-6 · Cited by 130 · see citing works

Statin safety: an assessment using an administrative claims database

Cziraky, M. J., Willey, V. J., McKenney, J. M., Kamat, S. A., Fisher, M. D., Guyton, J. R., Jacobson, T. A., & Davidson, M. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.011 · Cited by 130 · see citing works

Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease

Packard, C. J. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000236367.42755.c1 · Cited by 127 · see citing works

Effects of statin therapy on the progression of carotid atherosclerosis: a systematic review and meta-analysis

Kang, S., Wu, Y., & Li, X. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.005 · Cited by 126 · see citing works

Advanced method for the identification of patients with inherited hypercholesterolemia

Defesche, J., Lansberg, P., Umans-Eckenhausen, M., & Kastelein, J. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-822987 · Cited by 123 · see citing works

Low glycaemic index diets for coronary heart disease

Kelly, S. A., Frost, G., Whittaker, V., & Summerbell, C. D. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004467.pub2 · Cited by 122 · see citing works

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators

Cooney, M. T., Dudina, A., De Bacquer, D., Fitzgerald, A., Conroy, R., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., et al. (2009) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3283213140 · Cited by 121 · see citing works

Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: Focus on dietary proteins

Sirtori, C. R., Galli, C., Anderson, J. W., & Arnoldi, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.06.019 · Cited by 121 · see citing works

Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART

Calza, L., Manfredi, R., & Chiodo, F. (2003) · AIDS · doi:10.1097/00002030-200304110-00010 · Cited by 120 · see citing works

Characteristics of the Diet Patterns Tested in the Optimal Macronutrient Intake Trial to Prevent Heart Disease (OmniHeart): Options for a Heart-Healthy Diet

Swain, J. F., McCarron, P. B., Hamilton, E. F., Sacks, F. M., & Appel, L. J. (2008) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.10.040 · Cited by 112 · see citing works

Drug Therapy in the Heart Transplant Recipient: Part IV: Drug–Drug Interactions

Page, R. L., Miller, G. G., & Lindenfeld, J. (2005) · Circulation · doi:10.1161/01.cir.0000151805.86933.35 · Cited by 100 · see citing works

Combined therapy in the treatment of dyslipidemia

Reiner, Ž. (2010) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00764.x · Cited by 100 · see citing works

Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery?

Paraskevas, K. I., Liapis, C. D., Hamilton, G., & Mikhailidis, D. P. (2006) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2006.03.009 · Cited by 97 · see citing works

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)

Charlton-Menys, V., Betteridge, D. J., Colhoun, H., Fuller, J., France, M., Hitman, G. A., Livingstone, S. J., Neil, H. A. W., Newman, C. B., Szarek, M., et al. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.111401 · Cited by 94 · see citing works

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

on behalf of the FIELD study investigators, Taskinen, M.-R., Barter, P. J., Ehnholm, C., Sullivan, D. R., Mann, K., Simes, J., Best, J. D., Hamwood, S., & Keech, A. C. (2010) · Diabetologia · doi:10.1007/s00125-010-1806-9 · Cited by 94 · see citing works

The effect of select nutrients on serum high-density lipoprotein cholesterol and apolipoprotein A-I levels

Mooradian, A. D., Haas, M. J., & Wong, N. C. W. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0013 · Cited by 91 · see citing works

Lipid-Altering Efficacy and Safety of Ezetimibe/Simvastatin Coadministered With Extended-Release Niacin in Patients With Type IIa or Type IIb Hyperlipidemia

Guyton, J. R., Brown, B. G., Fazio, S., Polis, A., Tomassini, J. E., & Tershakovec, A. M. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.003 · Cited by 91 · see citing works

A Critical Evaluation of the Role of Soy Protein and Isoflavone Supplementation in the Control of Plasma Cholesterol Concentrations

Dewell, A., Hollenbeck, P. L. W., & Hollenbeck, C. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2350 · Cited by 90 · see citing works

Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk

Brown, B. G., & Zhao, X.-Q. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.039 · Cited by 84 · see citing works

Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials)

Murphy, S. A., Cannon, C. P., Wiviott, S. D., de Lemos, J. A., Blazing, M. A., McCabe, C. H., Califf, R. M., & Braunwald, E. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.053 · Cited by 82 · see citing works

Effect of statins on the progression of bioprosthetic aortic valve degeneration

Antonini-Canterin, F., Zuppiroli, A., Popescu, B. A., Granata, G., Cervesato, E., Piazza, R., Pavan, D., & Nicolosi, G. L. (2003) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.08.066 · Cited by 81 · see citing works

Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week multicenter, randomized, double-blind, controlled trial

Huijgen, R., Abbink, E. J., Bruckert, E., Stalenhoef, A. F. H., Imholz, B. P. M., Durrington, P. N., Trip, M. D., Eriksson, M., Visseren, F. L. J., Schaefer, J. R., et al. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.014 · Cited by 80 · see citing works

Pharmacokinetics and pharmacodynamics of combined use of lopinavir/ritonavir and rosuvastatin in HIV-infected patients

Van Der Lee, M., Sankatsing, R., Schippers, E., Vogel, M., Fätkenheuer, G., Van Der Ven, A., Kroon, F., Rockstroh, J., Wyen, C., Bäumer, A., et al. (2007) · Antiviral Therapy · doi:10.1177/135965350701200711 · Cited by 78 · see citing works

Statins: an essential component in the management of carotid artery disease

Paraskevas, K. I., Hamilton, G., & Mikhailidis, D. P. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.03.035 · Cited by 77 · see citing works

Genetic influences on blood lipids and cardiovascular disease risk: tools for primary prevention

Ordovas, J. M. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27113e · Cited by 74 · see citing works

Public perceptions of cardiovascular risk factors in Croatia: The PERCRO survey

Reiner, Ž., Sonicki, Z., & Tedeschi-Reiner, E. (2010) · Preventive Medicine · doi:10.1016/j.ypmed.2010.09.015 · Cited by 73 · see citing works

The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary care

García‐Rodríguez, L. A., Massó-González, E. L., Wallander, M.-A. A., & Johansson, S. (2008) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1603 · Cited by 65 · see citing works

Non-pharmacological control of plasma cholesterol levels

Poli, A., Marangoni, F., Paoletti, R., Mannarino, E., Lupattelli, G., Notarbartolo, A., Aureli, P., Bernini, F., Cicero, A., Gaddi, A., et al. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.004 · Cited by 63 · see citing works

Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate

Taskinen, M.-R., Sullivan, D. R., Ehnholm, C., Whiting, M., Zannino, D., Simes, R. J., Keech, A. C., & Barter, P. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.178228 · Cited by 63 · see citing works

Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment

Gränsbo, K., Melander, O., Wallentin, L., Lindbäck, J., Stenestrand, U., Carlsson, J., & Nilsson, J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.01.013 · Cited by 62 · see citing works

Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus--a pooled meta-analysis of randomized placebo-controlled clinical trials

Saha, S. A., & Arora, R. R. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.11.211 · Cited by 61 · see citing works

Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study

Jonsdottir (2002) · Journal of Cardiovascular Risk · doi:10.1097/00043798-200204000-00001 · Cited by 61 · see citing works

Combination statin-fibrate therapy: safety aspects

Franssen, R., Vergeer, M., Stroes, E. S. G., & Kastelein, J. J. P. (2009) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00917.x · Cited by 60 · see citing works

European guidelines on cardiovascular disease prevention in clinical practice: executive summary

Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,840 · see citing works

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Authors Task Force Members, Rydén, L., Grant, P. J., Anker, S. D., Berne, C., Cosentino, F., Danchin, N., Deaton, C., Escaned, J., Hammes, H., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,958 · see citing works

Effects of extended-release niacin with laropiprant in high-risk patients

The HPS2-THRIVE Collaborative Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300955 · Cited by 1,668 · see citing works

Dyslipidemia in obesity: Mechanisms and potential targets

Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

Anderson, T. J., Grégoire, J. C., Hegele, R. A., Couture, P., Mancini, G. B. J., McPherson, R., Francis, G. A., Poirier, P., Lau, D. C. W., Grover, S. A., et al. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.11.032 · Cited by 762 · see citing works

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

Hegele, R. A., Ginsberg, H. N., Chapman, M. J., Nordestgaard, B. G., Kuivenhoven, J. A., Averna, M., Borén, J., Bruckert, E., Catapano, A. L., Descamps, O. S., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70191-8 · Cited by 635 · see citing works

Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication

Benn, M., Watts, G. F., Tybjaerg-Hansen, A., & Nordestgaard, B. G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1563 · Cited by 632 · see citing works

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version

Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.15792 · Cited by 468 · see citing works

The prevalence, awareness, treatment and control of dyslipidemia among adults in China

Pan, L., Yang, Z., Wu, Y., Yin, R., Liao, Y., Wang, J., Gao, B., & Zhang, L. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.02.006 · Cited by 402 · see citing works

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

pre-diabetes Task Force on diabetes (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 236 · see citing works

Lipid-modifying effects of nutraceuticals: An evidence-based approach

Sahebkar, A., Șerban, M.-C., Gluba-Brzózka, A., Mikhailidis, D. P., Cicero, A. F. G., Rysz, J., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2016.04.007 · Cited by 188 · see citing works

Serum triglycerides and risk of cardiovascular disease

Boullart, A. C. I., Graaf, J. D., & Stalenhoef, A. F. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.002 · Cited by 157 · see citing works

Role of Nutrition in the Pathogenesis and Prevention of Non-alcoholic Fatty Liver Disease: Recent Updates

Ullah, R., Rauf, N., Nabi, G., Ullah, H., Shen, Y., Zhou, Y., & Fu, J. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30121 · Cited by 157 · see citing works

Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance

Baratta, F., Pastori, D., Polimeni, L., Bucci, T., Ceci, F., Calabrese, C. M., Ernesti, I., Pannitteri, G., Violi, F., Angelico, F., et al. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.371 · Cited by 146 · see citing works

Phytosterols, Phytostanols, and Lipoprotein Metabolism

Gylling, H., & Simonen, P. P. (2015) · Nutrients · doi:10.3390/nu7095374 · Cited by 140 · see citing works

Metabolic Syndrome and Male Fertility

Martins, A. D., Majzoub, A. A., & Agawal, A. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.180055 · Cited by 115 · see citing works

Transport, metabolism and remedial potential of functional food extracts (FFEs) in Caco-2 cells monolayer: A review

Iftikhar, M., Iftikhar, A., Zhang, H., Gong, L., & Wang, J. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109240 · Cited by 103 · see citing works

Carotid Plaque Characteristics and Disease Activity in Rheumatoid Arthritis

Semb, A. G., Rollefstad, S., Provan, S. A., Kvien, T. K., Stranden, E., Olsen, I. C., & Hisdal, J. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.120621 · Cited by 101 · see citing works

HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom

France, M. W., Rees, A., Datta, D. B. N., Thompson, G. R., Capps, N. E., Ferns, G. A., Ramaswami, U., Seed, M., Neely, D., Cramb, R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.017 · Cited by 101 · see citing works

Management of residual risk after statin therapy

Reith, C. A., & Armitage, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.018 · Cited by 91 · see citing works

Intensive LDL-cholesterol lowering therapy and neurocognitive function

Banach, M., Rizzo, M., Nikolić, D., Howard, G., Howard, V. J., & Mikhailidis (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.11.001 · Cited by 66 · see citing works

Cardiovascular risk prediction in HIV ‐infected patients: comparing the Framingham, atherosclerotic cardiovascular disease risk score ( ASCVD ), Systematic Coronary Risk Evaluation for the N etherlands (SCORE ‐ NL) and Data Collection on Adverse Events of Anti‐ HIV Drugs ( D : A : D ) risk prediction models

Krikke, M., Hoogeveen, R., Hoepelman, A. I. M., Visseren, F. L. J., & Arends, J. (2015) · HIV Medicine · doi:10.1111/hiv.12300 · Cited by 63 · see citing works

Nonstatin Low-Density Lipoprotein–Lowering Therapy and Cardiovascular Risk Reduction—Statement From <i>ATVB</i> Council

Hegele, R. A., Gidding, S. S., Ginsberg, H. N., McPherson, R., Raal, F. J., Rader, D. J., Robinson, J. G., & Welty, F. K. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.115.306442 · Cited by 63 · see citing works

Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey

Hovingh, G. K., Gandra, S. R., McKendrick, J., Dent, R. E., Wieffer, H., Catapano, A. L., OH, P. I., Rosenson, R. S., & Stroes, E. S. G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.12.015 · Cited by 62 · see citing works

Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall

Zanetti, M., Grillo, A., Losurdo, P., Panizon, E., Mearelli, F., Cattin, L., Barazzoni, R., & Carretta, R. (2015) · BioMed Research International · doi:10.1155/2015/791978 · Cited by 59 · see citing works

Lemon balm: A promising herbal therapy for patients with borderline hyperlipidemia—A randomized double-blind placebo-controlled clinical trial

Jandaghi, P., Noroozi, M., Ardalani, H., & Alipour, M. (2016) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2016.03.012 · Cited by 54 · see citing works

Lipid lowering drugs and the risk of recurrent venous thromboembolism

Delluc, A., Tromeur, C., Moigne, E. L., Nowak, E., Mottier, D., Gal, G. L., & Lacut, K. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.08.296 · Cited by 52 · see citing works

Multicenter Study to Determine the Diagnosis Criteria of Heterozygous Familial Hypercholesterolemia in Japan

Harada‐Shiba, M., Arai, H., Okamura, T., Yokote, K., Oikawa, S., Nohara, A., Okada, T., Ohta, T., Bujo, H., Watanabe, M., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.14159 · Cited by 50 · see citing works

Is lower and lower better and better? A re-evaluation of the evidence from the Cholesterol Treatment Trialists’ Collaboration meta-analysis for low-density lipoprotein lowering

Sniderman, A. D., Thanassoulis, G., Couture, P., Williams, K., Alam, A., & Furberg, C. D. (2012) · Journal of clinical lipidology · doi:10.1016/j.jacl.2012.05.004 · Cited by 49 · see citing works

Efficacy and Tolerability of a Nutraceutical Combination (Red Yeast Rice, Policosanols, and Berberine) in Patients with Low-Moderate Risk Hypercholesterolemia: A Double-Blind, Placebo-Controlled Study

Gonnelli, S., Caffarelli, C., Stolakis, K., Cuda, C., Giordano, N. G., & Nuti, R. (2014) · Current Therapeutic Research · doi:10.1016/j.curtheres.2014.07.003 · Cited by 49 · see citing works

Prevalence of familial hypercholesterolemia: a meta-analysis of six large, observational, population-based studies in Poland

Pająk, A., Szafraniec, K., Polak, M., Drygas, W., Piotrowski, W., Zdrojewski, T. R., & Jankowski, P. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.59700 · Cited by 48 · see citing works

A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids

Karalis, D. G. (2016) · Advances in Therapy · doi:10.1007/s12325-016-0462-y · Cited by 48 · see citing works

Monitoring of lipids, enzymes, and creatine kinase in patients on lipid-lowering drug therapy

Wiklund, O., Pirazzi, C., & Romeo, S. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0397-8 · Cited by 45 · see citing works

Management of lipid disorders in patients living with HIV

Myerson, M. L., Malvestutto, C., & Aberg, J. A. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.473 · Cited by 44 · see citing works

Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients

Shetty, S., Kumar, S., Mathur, R. P., Sharma, K. H., & Jaiswal, A. D. (2015) · Indian Heart Journal · doi:10.1016/j.ihj.2015.02.007 · Cited by 43 · see citing works

Glycated hemoglobin-detection methods based on electrochemical biosensors

Yazdanpanah, S., Rabiee, M., Tahriri, M., Abdolrahim, M., & Tayebi, L. (2015) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.03.019 · Cited by 43 · see citing works

What to say and how to say it

Návar, A. M., Stone, N. J., & Martin, S. S. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000322 · Cited by 43 · see citing works

PROMETHEUS: an observational, cross-sectional, retrospective study of hypertriglyceridemia in Russia

IuA, K., & Владиславовна, Х. Ю. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0268-2 · Cited by 42 · see citing works

The Additive Value of Femoral Ultrasound for Subclinical Atherosclerosis Assessment in a Single Center Cohort of 962 Adults, Including High Risk Patients with Rheumatoid Arthritis, Human Immunodeficiency Virus Infection and Type 2 Diabetes Mellitus

Protogerou, A. D., Fransen, J., Zampeli, E., Argyris, A., Aissopou, E., Arida, A., Konstantonis, G. D., Tentolouris, N., Makrilakis, K., Psichοgiou, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132307 · Cited by 41 · see citing works

Usefulness of Patients-Reported Outcomes in Rheumatoid Arthritis Focus Group

Amaya‐Amaya, J., Corzo, D. B., Calixto, O.-J., Calderon-Rojas, R. D., Domínguez, A. R., Cruz‐Tapias, P., Montoya-Ortiz, G., Mantilla, R.-D., Anaya, J., & Rojas‐Villarraga, A. (2012) · Arthritis · doi:10.1155/2012/935187 · Cited by 42 · see citing works

A spread containing bioactive milk peptides Ile–Pro–Pro and Val–Pro–Pro, and plant sterols has antihypertensive and cholesterol-lowering effects

Turpeinen, A. M., Ikonen, M., Kivimäki, A. S., Kautiainen, H., Vapaatalo, H., & Korpela, R. (2012) · Food & Function · doi:10.1039/c2fo10286b · Cited by 41 · see citing works

Dietary cholesterol and egg yolk should be avoided by patients at risk of vascular disease

Spence, J. D. (2016) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2016-0005 · Cited by 38 · see citing works

Antioxidant and hypolipidemic effects of soymilk fermented via Lactococcus acidophilus MF204

Chen, J., Wu, Y., Yang, C., Xu, X., & Meng, Y. (2017) · Food & Function · doi:10.1039/c7fo00701a · Cited by 38 · see citing works

ANALYSIS OF HYPERCHOLESTEROLEMIA PREVALENCE IN THE OUTPATIENT PRACTICE (ACCORDING TO THE ARGO STUDY): PART I

Ахмеджанов, Н. М., Небиеридзе, Д. В., Safaryan, A. S., Выгодин, В. А., Shuraev, A. Y., Tkacheva, O. N., & Лишута, А. С. (2015) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2015-11-3-253-260 · Cited by 36 · see citing works

Therapeutic Potential of Mipomersen in the Management of Familial Hypercholesterolaemia

Gelsinger, C., Steinhagen‐Thiessen, E., & Kassner, U. (2012) · Drugs · doi:10.2165/11635060-000000000-00000 · Cited by 35 · see citing works

Statin therapy is associated with reduced incidence of hypoxic hepatitis in critically ill patients

Drolz, A., Horvatits, T., Michl, B., Roedl, K., Schellongowski, P., Holzinger, U., Zauner, C., Heinz, G., Madl, C., Trauner, M. A., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.019 · Cited by 35 · see citing works

Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system

Sahebkar, A., Cicero, A. F. G., Giosia, P. D., Pomilio, I., Stamerra, C. A., Giorgini, P., Ferri, C., von Haehling, S., Banach, M., & Jamialahmadi, T. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12579 · Cited by 33 · see citing works

Landmark Lipid‐Lowering Trials in the Primary Prevention of Cardiovascular Disease

Chrispin, J., Martin, S. S., Hasan, R. K., Joshi, P. H., Minder, C. M., McEvoy, J. W., Kohli, P., Johnson, A. E., Wang, L., Blaha, M. J., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22147 · Cited by 36 · see citing works

Risk burdens of modifiable risk factors incorporating lipoprotein (a) and low serum albumin concentrations for first incident acute myocardial infarction

Yang, Q., He, Y., Cai, D.-P., Yang, X., & Xu, H. (2016) · Scientific Reports · doi:10.1038/srep35463 · Cited by 32 · see citing works

Effect of hazelnut on serum lipid profile and fatty acid composition of erythrocyte phospholipids in children and adolescents with primary hyperlipidemia: A randomized controlled trial

Deon, V., Bo’, C. D., Guaraldi, F., Abello, F., Belviso, S., Porrini, M., Riso, P., & Guardamagna, O. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.05.022 · Cited by 32 · see citing works

How to balance cardiorenometabolic benefits and risks of statins

Lim, S. K., Oh, P. C., Sakuma, I., & Koh, K. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.06.001 · Cited by 31 · see citing works

Gene silencing approaches for the management of dyslipidaemia

Norata, G. D., Tibolla, G., & Catapano, A. L. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.01.010 · Cited by 30 · see citing works

Lipoprotein apheresis in the management of severe hypercholesterolemia and of elevation of lipoprotein(a): current perspectives and patient selection

Julius, U. (2016) · Medical Devices Evidence and Research · doi:10.2147/mder.s98889 · Cited by 29 · see citing works

Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study

Yamashita, S., Masuda, D., Harada‐Shiba, M., Arai, H., Bujo, H., Ishibashi, S., Daida, H., Koga, N., & Oikawa, S. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.62764 · Cited by 29 · see citing works

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients

Bocchia, M., Galimberti, S., Aprile, L., Sicuranza, A., Gozzini, A., Santilli, F., Abruzzese, E., Baratè, C., Scappini, B., Fontanelli, G., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11100 · Cited by 29 · see citing works

Vascular effects of nonsteroidal antiinflammatory drugs

Soubrier, M., Rosenbaum, D. H., Tatar, Z., Lahaye, C., Dubost, J., & Mathieu, S. (2013) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.12.002 · Cited by 28 · see citing works

Effects of anacetrapib on plasma lipids in specific patient subgroups in the DEFINE (Determining the Efficacy and Tolerability of CETP INhibition with AnacEtrapib) trial

Brinton, E. A., Kher, U. A., Shah, S., Cannon, C. P., Davidson, M. H., Gotto, A. M., Ashraf, T. B., Sisk, C. M., Dansky, H. M., Mitchel, Y., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.10.005 · Cited by 27 · see citing works

Bariatric surgery and cardiovascular outcome

Ammar, W., Basset, H. A., Faramawy, A. E., Hegazy, T. O., & Sharaf, Y. (2020) · The Egyptian Heart Journal · doi:10.1186/s43044-020-00096-8 · Cited by 27 · see citing works

Risk of Acute Myocardial Infarction

Madssen, E., Laugsand, L. E., Wiseth, R., Mørkedal, B., Platou, C., VATTEN, L. J., & Janszky, I. (2013) · Epidemiology · doi:10.1097/ede.0b013e31829d2632 · Cited by 28 · see citing works

Postprandial dyslipidaemia and diabetes

Pang, J., Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328354c790 · Cited by 28 · see citing works

Prevalence and management of hypercholesterolemia in France, the Esteban observational study

Blacher, J., Gabet, A., Vallée, A., Ferrières, J., Bruckert, É., Farnier, M., & Olié, V. (2020) · Medicine · doi:10.1097/md.0000000000023445 · Cited by 26 · see citing works

Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy

Lorenzi, M. F., Ambegaonkar, B. M., Baxter, C. A., Jansen, J. P., Zoratti, M. J., & Davies, G. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1379-z · Cited by 26 · see citing works

The TELE-DD Randomised Controlled Trial on Treatment Adherence in Patients with Type 2 Diabetes and Comorbid Depression: Clinical Outcomes after 18-Month Follow-Up

del Hoyo, M. L. L., Fernández‐Rodrigo, M. T., Urcola‐Pardo, F., Monreal‐Bartolomé, A., Ruiz, D. C. G., Borao, M. G., Alcázar, A. B. A., Casbas, J. P. M., Casas, A. A., Funcia, M. T. A., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20010328 · Cited by 25 · see citing works

ApoB versus non-HDL-cholesterol: Diagnosis and cardiovascular risk management

de Nijs, T., Sniderman, A. D., & Graaf, J. D. (2013) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2013.847897 · Cited by 25 · see citing works

Superior role of waist circumference to body-mass index in the prediction of cardiometabolic risk in dyslipidemic patients.

Cibičková, Ľ., Langová, K., Vaverkova, H., Lukeš, J., Cibiček, N., & Karásek, D. (2019) · Physiological Research · doi:10.33549/physiolres.934176 · Cited by 16 · see citing works

Atherosclerosis: Comparative Pathogenesis, Lipoprotein Metabolism, and Avian and Exotic Companion Mammal Models

Beaufrère, H. (2013) · Journal of Exotic Pet Medicine · doi:10.1053/j.jepm.2013.10.016 · Cited by 23 · see citing works

Evaluation of plasma PCSK9 concentrations, transcript of LDL receptor, as well as the total number of monocyte LDL receptors in acute coronary syndrome patients

Burchardt, P., Rzeźniczak, J., Dudziak, J., Dżumak, A., Marchlewski, T., Ganowicz-Kaatz, T., Popiak, M., Słomczyński, M., Jezierski, M., Laskowski, W., et al. (2016) · Cardiology Journal · doi:10.5603/cj.a2016.0068 · Cited by 22 · see citing works

Post-discharge and long-term follow-up after an acute coronary syndrome: International Collaborative Group of CNCF position paper.

Sabouret, P. F., Lemesle, G., Bellemain-Appaix, A., Aubry, P., Bocchino, P.-P., Rafflenbeul, E., Belle, L., Nolan, J., Bernardi, M., Biondi‐Zoccai, G., et al. (2022) · Archives of Medical Science · doi:10.5114/aoms/150321 · Cited by 22 · see citing works

LOX-1 ligands containing apolipoprotein B and carotid intima-media thickness in middle-aged community-dwelling US Caucasian and Japanese men

Okamura, T., Sekikawa, A. M., Sawamura, T., Kadowaki, T., Barinas‐Mitchell, E., Mackey, R. H., Kadota, A., Evans, R. G., Edmundowicz, D., Higashiyama, A., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.023 · Cited by 21 · see citing works

LDL Cholesterol Goals in High-Risk Patients: How Low Do We Go and How Do We Get There?

Besseling, J., van Capelleveen, J. C., Kastelein, J. J. P., & Hovingh, G. K. (2013) · Drugs · doi:10.1007/s40265-013-0028-0 · Cited by 21 · see citing works

Increased chitotriosidase activity in plasma of patients with type 2 diabetes

Żurawska-Płaksej, E., Knapik-Kordecka, M., Rorbach-Dolata, A., & Piwowar, A. (2016) · Archives of medical science : AMS · doi:10.5114/aoms.2016.60093 · Cited by 19 · see citing works

TG/HDL-C Ratio Is a Risk Factor Associated with CKD: Use in Assessing the Risk of Progression of CKD

Ha, N. H., Tran, H. H., Nguyen, L. T., Nguyen, T. N., Nguyen, N. A., Vi, M. T., & Nguyen, K. T. (2022) · Pathophysiology · doi:10.3390/pathophysiology29030029 · Cited by 19 · see citing works

Do all lupus patients need statins?

Soubrier, M., Mathieu, S., Hermet, M., Makarawiez, C., & Bruckert, É. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.08.014 · Cited by 18 · see citing works

Diabetes Mellitus

Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.19349 · Cited by 18 · see citing works

Reproducibility of Cutaneous Vascular Conductance Responses to Slow Local Heating Assessed Using seven‐Laser Array Probes

Dawson, E. A., Low, D. A., Meeuwis, I. H. M., Kerstens, F. G., Atkinson, C. L., Cable, N. T., GREEN, D. J., & Thijssen, D. H. J. (2015) · Microcirculation · doi:10.1111/micc.12196 · Cited by 18 · see citing works

Difference between calculated and direct-measured low-density lipoprotein cholesterol in subjects with diabetes mellitus or taking lipid-lowering medications

Choi, S., Park, H. E., Kim, M. K., Shin, C. S., Cho, S., & Oh, B. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.12.007 · Cited by 18 · see citing works

Efficacy of Plant Sterol-Enriched Food for Primary Prevention and Treatment of Hypercholesterolemia: A Systematic Literature Review

Turini, E., Sarsale, M., Petri, D., Totaro, M., Lucenteforte, E., Tavoschi, L., & Baggiani, A. (2022) · Foods · doi:10.3390/foods11060839 · Cited by 17 · see citing works

Prevalence of persistent lipid abnormalities in statin‐treated patients: Belgian results of the Dyslipidaemia International Study ( DYSIS )

Devroey, D., Radermecker, R. P., der Schueren, B. V., Torbeyns, B., & Jaken, R. J. P. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12315 · Cited by 17 · see citing works

Predictive Value of Adiponectin in Patients with Multivessel Coronary Atherosclerosis Detected on Computed Tomography Angiography

Matsuda, M., Tamura, R., Kishida, N., Segawa, T., Kanno, K., Nishimoto, O., Nakamoto, K., Nishiyama, H., & Kawamoto, T. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.18036 · Cited by 17 · see citing works

Management standards for stable coronary artery disease in India

Mishra, S., Ray, S., Dalal, J. J., Sawhney, J. P. S., Ramakrishnan, S., Nair, T., Iyengar, S. S., & Bahl, V. K. (2016) · Indian Heart Journal · doi:10.1016/j.ihj.2016.11.320 · Cited by 17 · see citing works

Potential Effects of Reclassifying CKD as a Coronary Heart Disease Risk Equivalent in the US Population

Foster, M. C., Rawlings, A. M., Marrett, E., Neff, D., Grams, M. E., Kasiske, B. L., Willis, K., Inker, L. A., Coresh, J., & Selvin, E. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.11.014 · Cited by 16 · see citing works

Intensive risk factor control in stroke prevention

Spence, J. D. (2013) · F1000Prime Reports · doi:10.12703/p5-42 · Cited by 17 · see citing works

Metabolic syndrome and coronary artery disease in adults with congenital heart disease

Niwa, K. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-781 · Cited by 16 · see citing works

A Mobile Health-Based Disease Management Program Improves Blood Pressure in People With Multiple Lifestyle-Related Diseases at Risk of Developing Vascular Disease ― A Retrospective Observational Study ―

Kanai, M., Toda, T., Yamamoto, K., Akimoto, M., & Hagiwara, Y. (2022) · Circulation Reports · doi:10.1253/circrep.cr-22-0024 · Cited by 14 · see citing works

Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge

Rysz, J., Gluba-Brzózka, A., Banach, M., & Więcek, A. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-0937-9 · Cited by 14 · see citing works

Primary Hypertriglyceridemia: A Look Back on the Clinical Classification and Genetics of the Disease

Musambil, M., Al-Rubeaan, K. A., Al-Qasim, S., Alnaqeb, D., & Al-Soghayer, A. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666190502164131 · Cited by 16 · see citing works

Hipercolesterolemia familiar: artículo de revisión

Merchán, A., Ruiz, Á. J., Campo, R., Prada, C. E., Toro, J. M., Sánchez, R., Gómez‐Mesa, J. E., Jaramillo, N. I., Molina, D. I., Vargas‐Uricoechea, H., et al. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.05.002 · Cited by 14 · see citing works

Statin-associated muscle symptoms (SAMS) in primary prevention for cardiovascular disease in older adults: a protocol for a systematic review and meta-analysis of randomised controlled trials

Zhou, Z., Albarqouni, L., Breslin, M. C., Curtis, A. J., & Nelson, M. R. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017587 · Cited by 13 · see citing works

Strategies for screening for familial hypercholesterolaemia in primary care and other community settings

Qureshi, N., Silva, M. L. R. D., Abdul-Hamid, H., Weng, S. F., Kai, J., & Leonardi‐Bee, J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012985.pub2 · Cited by 13 · see citing works

Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study

Miura, T., Izawa, A., Motoki, H., Miyashita, Y., Kashima, Y., Ebisawa, S., Tomita, T., Koyama, J., & Ikeda, U. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127835 · Cited by 13 · see citing works

The curative treatment of familial hypercholesterolemia: Liver transplantation

Kirnap, N. G., Kırnap, M., Tütüncü, N. B., Moray, G., & Haberal, M. A. (2019) · Clinical Transplantation · doi:10.1111/ctr.13730 · Cited by 13 · see citing works

Combined Treatment with Amlodipine and Atorvastatin Calcium Reduces Circulating Levels of Intercellular Adhesion Molecule-1 and Tumor Necrosis Factor-α in Hypertensive Patients with Prediabetes

Huang, Z., Chen, C., Li, S., Kong, F., Shan, P., & Huang, W. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00206 · Cited by 12 · see citing works

Persistent lipid abnormalities in statin-treated coronary artery disease patients with and without diabetes in China

Wei, Y., Guo, H., The, E., Che, W., Shen, J., Hou, L., Zhao, S., Ye, P., Li, G., Wang, D., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.01.024 · Cited by 13 · see citing works

Cardiovascular risk factor control is insufficient in young patients with coronary artery disease

Christiansen, M. K., Jensen, J. M., Broendberg, A. K., Bøtker, H. E., & Jensen, H. K. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s106436 · Cited by 11 · see citing works

Double product reflects the association of heart rate with MACEs in acute coronary syndrome patients treated with percutaneous coronary intervention

Xu, T., Zhan, Y., Lu, N., He, Z., Su, X., & Tan, X. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0714-z · Cited by 10 · see citing works

Effectiveness of a diet with low advanced glycation end products, in improving glycoxidation and lipid peroxidation: a long-term investigation in patients with chronic renal failure

Chilelli, N. C., Cremasco, D., Cosma, C., Ragazzi, E., Pesenti, F. F., Bonfante, L., & Lapolla, A. (2015) · Endocrine · doi:10.1007/s12020-015-0805-5 · Cited by 10 · see citing works

Optimal Use of Plant Stanol Ester in the Management of Hypercholesterolemia

Rosin, S., Ojansivu, I. T., Kopu, A., Keto-Tokoi, M., & Gylling, H. (2015) · Cholesterol · doi:10.1155/2015/706970 · Cited by 10 · see citing works

Non-High-Density Lipoprotein Cholesterol Levels on the Risk of Asymptomatic Intracranial Arterial Stenosis: A Result from the APAC Study

Wu, J., Wang, A., Li, X., Wu, S., & Zhao, X. (2016) · Scientific Reports · doi:10.1038/srep37410 · Cited by 10 · see citing works

Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study

Hiro, T., Hirayama, A., Ueda, Y., Komatsu, S., Matsuoka, H., Takayama, T., Ishihara, M., Hayashi, T., Saito, S., & Kodama, K. (2014) · Journal of Cardiology · doi:10.1016/j.jjcc.2014.02.026 · Cited by 10 · see citing works

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162 · see citing works

2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Mach, F., Koskinas, K. C., van Lennep, J. E. R., Tokgözoğlu, L. S., Badimón, L., Baigent, C., Benn, M., Binder, C. J., Catapano, A. L., Backer, G. D., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120479 · Cited by 180 · see citing works

The european society of cardiology and the european atherosclerosis society (ESC/EAS) guidelines on the management of dyslipidemia

Reiner, Ž., Catapano, A. L., Backer, G. D., Graham, I., Taskinen, M., Wiklund, O., Agewall, S., Alegria, E. D., Chapman, M. J., Durrington, P. N., et al. (2011) · Revista Española de Cardiología · Cited by 4 · see citing works

The new joint EAS/ESC guidelines for the management of dyslipidaemias

Catapano, A. L., Chapman, J., Wiklund, O., & Taskinen, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.011 · Cited by 111 · see citing works

ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Catapano, A. L., Reiner, Z., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegría, E., Chapman, M. J., Durrington, P. N., et al. (2011) · Lenus, The Irish Health Repository (Dr Steevens Hospital Library) · Cited by 114 · see citing works